Travelers' VaccinesJane N. Zuckerman, Elaine C. Jong International and regional travel continues to grow; in recent years, disaster relief teams have joined the traditional ranks of travelers and face exposure to both commonplace and more exotic travel-associated infectious agents as a consequence of deteriorating and uncertain environmental conditions. The prevention of infectious disease is a major goal of the clinical practice of travel medicine, and the protection of travelers against vaccine-preventable diseases remains one of the most effective interventions in promoting travelers' health. Travelers' Vaccines 2e includes chapters that have been updated to reflect the development of new, more immunogenic and safer vaccines for rotavirus, meningococcal disease, hepatitis B, and Japanese encephalitis. Recent changes in vaccine recommendations are covered, and new chapters have been added to address the emergence and spread of infectious diseases such as avian influenza and tick-borne encephalitis. Other chapters present current perspectives and future directions for vaccines against yellow fever, dengue fever, rabies, and travelers' diarrhea. Chapters of vaccine immunology, administration, safety, and economics, as well as chapters on immunizations in special populations, round out this comprehensive resource. |
Other editions - View all
Common terms and phrases
accessed active addition administration adults adverse events animal antibody antigens areas associated attenuated blood booster cause cells Centers challenge cholera Clin clinical combined component conjugate considered contains Control countries dengue disease dose effective efficacy endemic epidemic estimated et al evaluation exposure flavivirus given hepatitis host human immune response immunogenicity important inactivated incidence increased indicated individuals infants infection influenza International Japanese encephalitis levels live malaria manufacturer meningococcal migrants months natural occur oral Organization outbreak patients Pediatr persons phase polysaccharide population Practices pregnancy Prevention production programs protection protein rabies rates reactions receive recent recommended reduced regions reported result risk routine safe safety schedule severe single specific strain studies testing tion transmission treatment trial tuberculosis typhoid United vaccine Vibrio cholerae viral virus viruses weeks World yellow fever